Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)
Dipòsit Digital de la UB
oai:diposit.ub.edu:2445/163704
Dataset. 2020

DATASET FROM EFFECTIVENESS OF CONSUMERS WASHING WITH SANITIZERS TO REDUCE HUMAN NOROVIRUS ON MIXED SALAD

  • Anfruns-Estrada, Eduard
  • Bottaro, Marilisa
  • Pintó Solé, Rosa María
  • Guix Arnau, Susana
  • Bosch, Albert
Data associated to the article published at Foods, 2019, vol. 8, num. 12, p. 637, https://doi.org/10.3390/foods8120637, Podeu consultar l'article associat a: http://hdl.handle.net/2445/158144, Viral titers were collected following a method based on the ISO 15216-1 (2017) protocol with some modifications, on experimentally inoculated ready-to-eat vegetables. See Materials and Methods section of the manuscript. Effect of the sanitizer wash on virus reduction was determined by calculating the log units (Nt/N0), where N0 is the titer of virus recovered on unwashed control samples and Nt is the titer of virus recovered on washed sample.

Proyecto: //
DOI: http://hdl.handle.net/2445/163704
Dipòsit Digital de la UB
oai:diposit.ub.edu:2445/163704
HANDLE: http://hdl.handle.net/2445/163704
Dipòsit Digital de la UB
oai:diposit.ub.edu:2445/163704
PMID: http://hdl.handle.net/2445/163704
Dipòsit Digital de la UB
oai:diposit.ub.edu:2445/163704
Ver en: http://hdl.handle.net/2445/163704
Dipòsit Digital de la UB
oai:diposit.ub.edu:2445/163704

Dipòsit Digital de la UB
oai:diposit.ub.edu:2445/173199
Dataset. 2021

DATA ON THE EFFECT OF EARLY TREATMENT WITH IVERMECTIN ON VIRAL LOAD, SYMPTOMS AND HUMORAL RESPONSE IN PATIENTS WITH MILD COVID-19

  • Chaccour, Carlos
  • Casellas, Aina
  • Blanco-Di Matteo, Andrés
  • Pineda, Iñigo
  • Fernández Montero, Alejandro
  • Ruiz Castillo, Paula
  • Richardson, Mary-Ann
  • Rodríguez Mateos, Mariano
  • Jordán Iborra, Carlota
  • Brew, Joe
  • Carmona Torre, Francisco
  • Giráldez, Miriam
  • Laso, Ester
  • Dobaño, Carlota, 1969-
  • Moncunill, Gemma
  • Yuste, José R.
  • Pozo, José L. del
  • Rabinovich, Regina
  • Schöning, Verena
  • Hammann, Felix
  • Reina, Gabriel
  • Sadaba, Belen
  • Fernández Alonso, Miriam
Dades primàries associades a l'article publicat a EClinicalMedicine, vol. 32 [https://doi.org./10.1016/j.eclinm.2020.100720], The trial was conducted in the Pamplona metropolitan area (Navarra, Spain). Patients were enrolled between July 31, 2020 and September 11, 2020 and randomized in a 1:1 ratio to ivermectin (400 mcg/kg) single oral dose or placebo. Assessments on enrollment and at days 4, 7, 14, 21 and 28 post treatment included: general symptoms report, physical examination and adverse events. All patients were asked to complete a daily online diary of symptoms from day 1 to 28 post treatment. On enrollment, as well as on days 7 and 14 blood samples were obtained to assess full blood count, C reactive protein, procalcitonin, ferritin, creatinine phosphokinase, lactic dehydrogenase, troponin T, D dimer, IL-6, and renal function. Viral loads were calculated at enrollment and on days 4, 7, 14 and 21 post treatment based on a nasopharyngeal swab for SARS-CoV-2 PCR (for genes N and E). A semi-quantitative serology for IgG against SARS-CoV-2 was done on samples from all patients on day 21 post-treatment.

Proyecto: //
DOI: http://hdl.handle.net/2445/173199
Dipòsit Digital de la UB
oai:diposit.ub.edu:2445/173199
HANDLE: http://hdl.handle.net/2445/173199
Dipòsit Digital de la UB
oai:diposit.ub.edu:2445/173199
PMID: http://hdl.handle.net/2445/173199
Dipòsit Digital de la UB
oai:diposit.ub.edu:2445/173199
Ver en: http://hdl.handle.net/2445/173199
Dipòsit Digital de la UB
oai:diposit.ub.edu:2445/173199

Buscador avanzado